CHEOY:OTCMKTS
Cochlear Ord ADR
45,44 USD
arrow_upward
+1,61%(+0,72) 1 d.
16. 10., 16:00:00 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre CHEOY…
Otvoriť
43,84 USD
Vysoká
46,04 USD
Nízka
43,84 USD
Trh. kap.
8,58 mld.
Priem. obj.
18,60 tis.
Objem
29,16 tis.
Max. za 52 týž.
98,49 USD
Min. za 52 týž.
31,82 USD
Beta
0,68
Akcie v obehu
130,80 mil.
Počet zamestnancov
5 tis.
Otvoriť
43,84 USD
Vysoká
46,04 USD
Nízka
43,84 USD
Trh. kap.
8,58 mld.
Priem. obj.
18,60 tis.
Objem
29,16 tis.
Max. za 52 týž.
98,49 USD
Min. za 52 týž.
31,82 USD
Beta
0,68
Akcie v obehu
130,80 mil.
Počet zamestnancov
5 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Simply Wall Street
·
pred 1 dňom
Cochlear And 2 Australian Healthcare Stocks To Watch
PR Newswire
·
pred 2 dňami
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Profil
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Informácie o subjekte Cochlear Ord ADR
Generálny riaditeľDig Howitt
Zamestnanci5,4 tis.
Dátum založenia1981
Hlavné sídloSydney, Nový Južný Wales, Austrália
Odvetvie-
Webcochlear.com